Regeneron Pharmaceuticals, Inc.
Solute Carrier Family 26 Member 5 (SLC26A5) Variants And Uses Thereof
Last updated:
Abstract:
The present disclosure provides methods of treating a subject having hearing loss, methods of identifying a subject having an increased risk of developing hearing loss, and methods of detecting Solute Carrier Family 26 Member 5 (SLC26A5) variant nucleic acid molecules and variant polypeptides.
Status:
Application
Type:
Utility
Filling date:
5 May 2021
Issue date:
2 Dec 2021